Pancreatitis with Pancreatic Tail Swelling Associated with Incretin-based Therapies Detected Radiologically in Two Cases of Diabetic Patients with End-Stage Renal Disease-Reference-Cited by-同舟云学术

Pancreatitis with Pancreatic Tail Swelling Associated with Incretin-based Therapies Detected Radiologically in Two Cases of Diabetic Patients with End-Stage Renal Disease

Published:2012 Issue:21 Volume:51 Page:3045-3049
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Nakata Hirosuke¹,Sugitani Seita¹,Yamaji Shuhei¹,Otsu Satoko¹,Higashi Yoshihito¹,Ohtomo Yumiko¹,Inoue Gen²

Affiliation:

1. Department of Nephrology, Japanese Red Cross Society Wakayama Medical Center, Japan

2. Department of Diabetes and Endocrinology, Japanese Red Cross Society Wakayama Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/21/51_51.7876/_pdf

Reference18 articles.

1. 1. Marre M, Shaw J, Brändle M, et al. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med 26: 268-278, 2009.

2. Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

3. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

4. 4. Zinman B, Gerich J, Buse JB, et al. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). Diabetes Care 32: 1224-1230, 2009.

5. 5. Russell-Jones D, Vaag A, Schmitz O, et al. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia 52: 2046-2055, 2009.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment;Gastroenterology Insights;2024-02-18

2. Liraglutide-Induced Pancreatitis: A Case Report and Literature Review;Cureus;2023-04-28

3. Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2022-10-24

4. Adverse drug reactions of GLP-1 agonists: A systematic review of case reports;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-03

5. Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives;Medical Principles and Practice;2020-08-20